FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

2.

PSMA PET Beats MRI in Prostate Cancer Staging Study

3.

Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic

4.

Using AI, one can find cancer risk factors.

5.

Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot